Initial clinical outcomes for prostate cancer patients undergoing adjuvant or salvage proton therapy after radical prostatectomy

Acta Oncol. 2020 Oct;59(10):1235-1239. doi: 10.1080/0284186X.2020.1766698. Epub 2020 May 18.

Authors

Curtiland Deville Jr¹, Wei-Ting Hwang², Andrew R Barsky³, Stefan Both⁴, John P Christodouleas³, Justin E Bekelman³, Zelig Tochner³, Neha Vapiwala³

Affiliations

¹ Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University, Baltimore, MD, USA.
² Department of Biostatistics, Epidemiology, and Informatics, University of Pennsylvania, Philadelphia, PA, USA.
³ Department of Radiation Oncology, University of Pennsylvania, Philadelphia, PA, USA.
⁴ Department of Radiation Oncology, University Medical Center Groningen, Groningen, Netherlands.

PMID: 32421456
DOI: 10.1080/0284186X.2020.1766698

No abstract available

Publication types

Letter

MeSH terms

Humans
Male
Neoplasm Recurrence, Local
Prostate-Specific Antigen
Prostatectomy
Prostatic Neoplasms* / radiotherapy
Prostatic Neoplasms* / surgery
Proton Therapy*
Retrospective Studies
Salvage Therapy

Substances

Prostate-Specific Antigen